[Federal Register Volume 74, Number 190 (Friday, October 2, 2009)]
[Notices]
[Page 50960]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23769]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Monoclonal 
Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/239,266 entitled ``Monoclonal Antibodies Against Glycoprotein of 
Ebola Sudan Boniface Virus,'' filed September 2, 2009. The United 
States Government, as represented by the Secretary of the Army, has 
rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Material Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Assessment, (301) 619-6664, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates generally to the field 
of antibodies. More specifically the invention relates to monoclonal 
antibodies against glycoproteins of the Ebola Sudan Boniface virus and 
methods of producing and using the same.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E9-23769 Filed 10-1-09; 8:45 am]
BILLING CODE 3710-08-P